Physician

Natale Tate Sheehan, MD

According to 2025 Medicare claims, Natale Sheehan, MD (NPI: 1518178524) practices hematology/oncology in the Jackson, MS market, with the plurality of this provider's patient population coming from Rankin, MS. This provider's primary affiliated billing organization is JACKSON ONCOLOGY ASSOCIATES (NPI: 1295776136; TIN: 640619700) and primary practice location at 39202-2002.

Sheehan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 818 traditional Medicare patients, billed 208,898 HCPCS/CPT codes, and received $4,012,369 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,060 prescription claims across 339 beneficiaries totaling $4,130,621 in drug costs, led by Lenalidomide (Lenalidomide). 2023 DME data shows 40 claims. Open Payments data shows 34 records totaling $32,287. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $63,126 to $4,012,369. Similarly, Part D prescription costs have moved sharply higher in recent years, from $537,578 to $4,130,621. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,058 to $5,404.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	265	750	$63,126
2016	262	864	$73,967
2017	250	772	$63,426
2018	763	90,434	$1,401,395
2019	846	200,719	$3,027,523
2020	811	258,296	$3,566,374
2021	778	224,180	$3,057,844
2022	768	226,206	$3,149,018
2023	799	237,426	$3,852,334
2024	818	208,898	$4,012,369

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	108	694	$537,578
2016	140	856	$610,908
2017	152	1,141	$766,239
2018	235	1,145	$613,201
2019	305	1,725	$1,702,428
2020	298	2,010	$2,239,128
2021	305	1,734	$2,777,058
2022	291	1,932	$3,614,822
2023	314	2,000	$3,253,465
2024	339	2,060	$4,130,621

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	26	106	$15,448
2020	24	119	$10,255
2021	N/R	128	$9,237
2022	N/R	40	$1,859
2023	N/R	40	$7,665
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	480	797	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	253	292	$65
80053	Blood test, comprehensive group of blood chemicals	563	1,986	$10
36415	Insertion of needle into vein for collection of blood sample	512	1,503	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	562	2,051	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	78	2,002	$1,186,057
Brukinsa	Zanubrutinib	29	870	$397,560
Imbruvica	Ibrutinib	25	700	$372,371
Revlimid	Lenalidomide	26	602	$366,824
Lynparza	Olaparib	16	480	$260,361

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$594	Celgene Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$31,693	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Natale Tate Sheehan, MD?

Tedicare shows public-source Medicare data for Natale Tate Sheehan, MD (NPI 1518178524), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Natale Tate Sheehan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Natale Tate Sheehan, MD?

Natale Tate Sheehan, MD is linked to JACKSON ONCOLOGY ASSOCIATES (billing NPI 1295776136) in the available physician profile data.

Does Natale Tate Sheehan, MD have Open Payments data?

Natale Tate Sheehan, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.